Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man

J. A. DiNardo, A. Bert, Michael Schwartz, R. G. Johnson, R. L. Thurer, R. M. Weintraub

Research output: Contribution to journalArticle

Abstract

Vasoactive agents are commonly used in the postcardiopulmonary bypass period to elevate the mean arterial pressure of myocardial revascularization patients. Concern exists that administration of vasoactive agents in this setting may affect flow through saphenous vein and internal mammary artery grafts. Twenty-eight patients were randomly assigned to receive one of the six two-drug combinations of phenylephrine, norepinephrine, and epinephrine. After termination of cardiopulmonary bypass baseline, hemodynamic measurements and electromagnetic flow probe measurements of saphenous vein and internal mammary artery graft flow were made. The first agent was then infused to elevate mean arterial pressure 20 mm Hg. After 5 minutes of stability, hemodynamic and graft flow measurements were repeated. The infusion was terminated, 5 minutes of stability were obtained, and baseline measurements were repeated. The second agent was then infused, and measurements were repeated after a 5-minute stabilization period. Phenylephrine induced a nonsignificant increase in saphenous vein graft flow (68 ± 31 versus 81 ± 49 ml/min) and a significant decrease in internal mammary artery graft flow (40 ± 16 versus 32 ± 12 ml/min). Norepinephrine induced a significant increase in saphenous vein graft flow (80 ± 39 versus 97 ± 39 ml/min) and no significant change in internal mammary artery graft flow (44 ± 20 versus 45 ± 20 ml/min). Epinephrine induced a significant increase in both saphenous vein (82 ± 38 versus 96 ± 40 ml/min) and internal mammary artery (38 ± 12 versus 55 ± 24 ml/min) graft flows. We conclude that administration of vasoactive agents in the postcardiopulmonary bypass period may significantly affect saphenous vein and internal mammary artery graft flows.

Original languageEnglish (US)
Pages (from-to)730-735
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume102
Issue number5
StatePublished - Dec 1 1991
Externally publishedYes

Fingerprint

Mammary Arteries
Saphenous Vein
Transplants
Pharmaceutical Preparations
Phenylephrine
Epinephrine
Norepinephrine
Arterial Pressure
Hemodynamics
Myocardial Revascularization
Electromagnetic Phenomena
Drug Combinations
Cardiopulmonary Bypass

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. / DiNardo, J. A.; Bert, A.; Schwartz, Michael; Johnson, R. G.; Thurer, R. L.; Weintraub, R. M.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 102, No. 5, 01.12.1991, p. 730-735.

Research output: Contribution to journalArticle

DiNardo, J. A. ; Bert, A. ; Schwartz, Michael ; Johnson, R. G. ; Thurer, R. L. ; Weintraub, R. M. / Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. In: Journal of Thoracic and Cardiovascular Surgery. 1991 ; Vol. 102, No. 5. pp. 730-735.
@article{a8107de496984516accb31a4dfab4d83,
title = "Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man",
abstract = "Vasoactive agents are commonly used in the postcardiopulmonary bypass period to elevate the mean arterial pressure of myocardial revascularization patients. Concern exists that administration of vasoactive agents in this setting may affect flow through saphenous vein and internal mammary artery grafts. Twenty-eight patients were randomly assigned to receive one of the six two-drug combinations of phenylephrine, norepinephrine, and epinephrine. After termination of cardiopulmonary bypass baseline, hemodynamic measurements and electromagnetic flow probe measurements of saphenous vein and internal mammary artery graft flow were made. The first agent was then infused to elevate mean arterial pressure 20 mm Hg. After 5 minutes of stability, hemodynamic and graft flow measurements were repeated. The infusion was terminated, 5 minutes of stability were obtained, and baseline measurements were repeated. The second agent was then infused, and measurements were repeated after a 5-minute stabilization period. Phenylephrine induced a nonsignificant increase in saphenous vein graft flow (68 ± 31 versus 81 ± 49 ml/min) and a significant decrease in internal mammary artery graft flow (40 ± 16 versus 32 ± 12 ml/min). Norepinephrine induced a significant increase in saphenous vein graft flow (80 ± 39 versus 97 ± 39 ml/min) and no significant change in internal mammary artery graft flow (44 ± 20 versus 45 ± 20 ml/min). Epinephrine induced a significant increase in both saphenous vein (82 ± 38 versus 96 ± 40 ml/min) and internal mammary artery (38 ± 12 versus 55 ± 24 ml/min) graft flows. We conclude that administration of vasoactive agents in the postcardiopulmonary bypass period may significantly affect saphenous vein and internal mammary artery graft flows.",
author = "DiNardo, {J. A.} and A. Bert and Michael Schwartz and Johnson, {R. G.} and Thurer, {R. L.} and Weintraub, {R. M.}",
year = "1991",
month = "12",
day = "1",
language = "English (US)",
volume = "102",
pages = "730--735",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man

AU - DiNardo, J. A.

AU - Bert, A.

AU - Schwartz, Michael

AU - Johnson, R. G.

AU - Thurer, R. L.

AU - Weintraub, R. M.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Vasoactive agents are commonly used in the postcardiopulmonary bypass period to elevate the mean arterial pressure of myocardial revascularization patients. Concern exists that administration of vasoactive agents in this setting may affect flow through saphenous vein and internal mammary artery grafts. Twenty-eight patients were randomly assigned to receive one of the six two-drug combinations of phenylephrine, norepinephrine, and epinephrine. After termination of cardiopulmonary bypass baseline, hemodynamic measurements and electromagnetic flow probe measurements of saphenous vein and internal mammary artery graft flow were made. The first agent was then infused to elevate mean arterial pressure 20 mm Hg. After 5 minutes of stability, hemodynamic and graft flow measurements were repeated. The infusion was terminated, 5 minutes of stability were obtained, and baseline measurements were repeated. The second agent was then infused, and measurements were repeated after a 5-minute stabilization period. Phenylephrine induced a nonsignificant increase in saphenous vein graft flow (68 ± 31 versus 81 ± 49 ml/min) and a significant decrease in internal mammary artery graft flow (40 ± 16 versus 32 ± 12 ml/min). Norepinephrine induced a significant increase in saphenous vein graft flow (80 ± 39 versus 97 ± 39 ml/min) and no significant change in internal mammary artery graft flow (44 ± 20 versus 45 ± 20 ml/min). Epinephrine induced a significant increase in both saphenous vein (82 ± 38 versus 96 ± 40 ml/min) and internal mammary artery (38 ± 12 versus 55 ± 24 ml/min) graft flows. We conclude that administration of vasoactive agents in the postcardiopulmonary bypass period may significantly affect saphenous vein and internal mammary artery graft flows.

AB - Vasoactive agents are commonly used in the postcardiopulmonary bypass period to elevate the mean arterial pressure of myocardial revascularization patients. Concern exists that administration of vasoactive agents in this setting may affect flow through saphenous vein and internal mammary artery grafts. Twenty-eight patients were randomly assigned to receive one of the six two-drug combinations of phenylephrine, norepinephrine, and epinephrine. After termination of cardiopulmonary bypass baseline, hemodynamic measurements and electromagnetic flow probe measurements of saphenous vein and internal mammary artery graft flow were made. The first agent was then infused to elevate mean arterial pressure 20 mm Hg. After 5 minutes of stability, hemodynamic and graft flow measurements were repeated. The infusion was terminated, 5 minutes of stability were obtained, and baseline measurements were repeated. The second agent was then infused, and measurements were repeated after a 5-minute stabilization period. Phenylephrine induced a nonsignificant increase in saphenous vein graft flow (68 ± 31 versus 81 ± 49 ml/min) and a significant decrease in internal mammary artery graft flow (40 ± 16 versus 32 ± 12 ml/min). Norepinephrine induced a significant increase in saphenous vein graft flow (80 ± 39 versus 97 ± 39 ml/min) and no significant change in internal mammary artery graft flow (44 ± 20 versus 45 ± 20 ml/min). Epinephrine induced a significant increase in both saphenous vein (82 ± 38 versus 96 ± 40 ml/min) and internal mammary artery (38 ± 12 versus 55 ± 24 ml/min) graft flows. We conclude that administration of vasoactive agents in the postcardiopulmonary bypass period may significantly affect saphenous vein and internal mammary artery graft flows.

UR - http://www.scopus.com/inward/record.url?scp=0026355389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026355389&partnerID=8YFLogxK

M3 - Article

C2 - 1682533

AN - SCOPUS:0026355389

VL - 102

SP - 730

EP - 735

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 5

ER -